Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition - Wikidata - awgldk - TriplyDB

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

http://www.wikidata.org/entity/Q34984217

about

Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells TNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanisms Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs.Astrocytes enhance the invasion potential of glioblastoma stem-like cells Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models.Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release.Potentiating effects of GHRH analogs on the response to chemotherapy.Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins.The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer A microengineered pathophysiological model of early-stage breast cancer.Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort.Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion.Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell line Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion.Didymin reverses phthalate ester-associated breast cancer aggravation in the breast cancer tumor microenvironment Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma.HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors.Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface.Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma Accumulation of pro-cancer cytokines in the plasma fraction of stored packed red cells.Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1.Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes.CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment

P2860

Q26784324-D4C0D054-D8ED-414A-9ED6-827D0B4FD095 Q28397726-2F2403E1-B0D7-43E6-8FFF-26B8FE48C64A Q30503693-2700B3AD-53C6-45F8-9409-E53F64258932 Q33587770-0466E6AB-F2A5-4150-A49C-8A94751A1187 Q33602761-02AE38CD-EDFF-4590-9069-74DF930CD298 Q33747708-E503F315-F66C-4FB8-8968-E88431EC075A Q33854379-177958B3-E0C4-434E-8FD0-F29E74586260 Q34038395-E1055C88-72DA-4F2E-8D1B-9439137A7F5F Q34528303-9BC8C3AA-60E4-428C-9AC9-B43E584C42BA Q34563444-8A0ED32D-9E0C-4DEB-B7E4-6033ED75F532 Q34713778-C5EEFF35-4386-4283-8D72-2EFCD4EE2404 Q34781112-D1B3C7AF-2E60-44C3-9604-140404C43528 Q35161856-C65734EF-3E1C-4359-866B-7F900A675666 Q35290842-F9997E4F-345B-4E2D-BC3E-28AFCBAF5A70 Q35565027-CE29AF8B-2364-449F-A450-B3D4AC89B2EE Q35569609-22922643-AF42-4385-8EF2-D4C6E006A340 Q35634563-3F6134F4-CB81-4A61-905E-77363A4467AB Q35674876-6B5AA779-D04C-4E03-B275-2FA184132FA4 Q35710589-3E6DB09F-A1F6-4C43-BA29-57903DEACF77 Q35748219-6E172C07-A9FF-414C-B38E-62144FB512FE Q35763876-448AA672-E175-4DCF-9737-11B5DFB77A6E Q35781425-C46387E1-C1E5-4B0D-8397-6DE2CDB58412 Q35916132-9AD289E4-78C6-42C0-8B25-67C15DE2167D Q36071192-8CDD42D6-2C22-41C8-B883-F5EAB610840D Q36107928-FB31073A-B120-41E4-9862-2D324002E5C2 Q36112190-F6CC2EFB-3552-4459-A490-8055721ADAA2 Q36510571-A38EAB27-2CD3-4CF5-9D10-F1C87D53F0E5 Q36524400-52C813CD-E3E8-47AF-AB20-F51D70D6A2FB Q36532342-06F5624D-5FF2-4ABE-974E-C49DCA2DD55D Q36619045-1AF167C5-36CA-45B9-819C-C99DF50DB128 Q36632887-FE78D95D-FBCA-4F27-8D79-2B5933AA05D9 Q36695074-14EA17F8-E9C5-4EE5-A659-3AFFA7B3CF14 Q36806793-1CFCFA11-0D9F-44A8-8A65-9346E3DA33DA Q36862773-622576E3-96E4-46DF-B70E-E61B7B0F0974 Q36905652-D8493C2C-58C0-4E64-876C-39EB5D30220F Q36950020-D434989C-21EA-4B48-9883-325D09CC4806 Q37012199-589E2F08-BCCB-4E16-A894-9A0F7C1E49C7 Q37027092-1DFE4077-8DCB-4978-AA9C-5BFC3E83C391 Q37085840-8364038A-35D5-48DD-BA09-80F50BF55951 Q37113471-A9BEE1B1-A470-46C8-BF68-C1C6D3F804E7

P2860

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

http://www.wikidata.org/entity/Q34984217

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@ast

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@en

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@nl

type

label

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@ast

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@en

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@nl

prefLabel

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@ast

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@en

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@nl

P1433

Q34984217-697B477E-4FAA-44CB-800D-87B330BACAF9

P1476

Q34984217-E814689E-78F1-4EB2-8C15-F238EAB6468C

P2093

Q34984217-0D427E8B-F36D-4B7B-8221-F7EB08CBD32D

Q34984217-182DB213-1E6B-4F2D-A80A-0B91DD900673

Q34984217-63606216-EFBE-455A-852A-C76F43FE8B95

Q34984217-728E7E26-28CB-4EA8-83FA-BE2B4D14A674

Q34984217-84D1BECB-D851-4A49-A2FF-935B006E77E9

Q34984217-919946A3-ECB1-4EF1-9DC1-E2BE037E4237

Q34984217-92FEE57E-42D9-4841-A91F-10E7B96480D1

Q34984217-994CF173-1650-44A6-BD01-55433833CAD6

Q34984217-C36EB122-78E6-4808-895D-B182A1F5F967

Q34984217-D2900A98-5328-4105-BFC7-80BE3CF9574F

P2860

Q34984217-02CC1202-12DF-4D84-B7E9-8A59B3483A15

Q34984217-04B520AE-DBEC-4AC6-9A1C-077327703140

Q34984217-0685A798-767F-4A6C-8D34-E937EE7BDFC1

Q34984217-10C0A923-CC9A-40A7-AF55-AC16C1A74BBF

Q34984217-14319AFB-FC07-4D04-A144-5CEAA82226E9

Q34984217-1AC54AE7-83C1-4581-80E9-9A582B5B0CFF

Q34984217-1BA8FC74-A721-4EDA-BD85-96236FB310DE

Q34984217-225AFEBD-3FDA-456C-B362-64DDE0839C1E

Q34984217-2F82E6A0-9444-4213-8352-1E19C3C69B5B

Q34984217-2F8B1F6A-F7FA-49E5-988A-4D7911889E7B

P2888

Q34984217-5DE723BE-5E71-4CCF-B9ED-351D07FE5C7F

P304

Q34984217-FE005178-2D72-4F8E-8E2A-C7A69849865F

P31

Q34984217-E797EBF0-384A-4633-A4FA-821558C3C3A9

P356

Q34984217-F0570702-84AA-49D2-888E-A05E95A4C0BC

P407

Q34984217-BF672CFD-BE5D-4CAB-87CB-9EA16082F4D7

P478

Q34984217-1A00B791-E97B-4C8C-9A4F-0400FE1EBF3B

P50

Q34984217-AA781724-A612-4A5C-B32B-5FF6FB03317C

P577

Q34984217-7F612B5C-5D18-4345-9851-1BD085521689

P5875

Q34984217-F40DDD92-02AC-4159-BF48-1F447AF99046

P6179

Q34984217-C2F0C31C-695F-42C7-A4F7-448CB404C0B0

P698

Q34984217-E8524220-2757-4F8D-B944-CC5F914BC660

P921

Q34984217-020D0780-D8A2-427F-8306-2A6B31065E08

P932

Q34984217-851A9C0B-E34F-46B5-90FF-6954295B8432

P356

1471-2407-11-130

P1433

P1476

Inflammatory mediators in brea ...... lial-to-mesenchymal transition

@en

P2093

Adit Ben-Baruch

http://www.w3.org/2001/XMLSchema#string

Esther Shabtai

http://www.w3.org/2001/XMLSchema#string

Gali Soria

http://www.w3.org/2001/XMLSchema#string

Ilana Haas

http://www.w3.org/2001/XMLSchema#string

Leonor Leider-Trejo

http://www.w3.org/2001/XMLSchema#string

Maya Ofri-Shahak

http://www.w3.org/2001/XMLSchema#string

Mordechai Gutman

http://www.w3.org/2001/XMLSchema#string

Neora Yaal-Hahoshen

http://www.w3.org/2001/XMLSchema#string

Tal Leibovich-Rivkin

http://www.w3.org/2001/XMLSchema#string

Tsipi Meshel

http://www.w3.org/2001/XMLSchema#string

P2860

Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation

Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

Breast lesions, pathology and cancer risk.

Treatment of DCIS--results from clinical trials.

A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.

Oestrogen receptor negative breast cancers exhibit high cytokine content

Ductal carcinoma in situ, complexities and challenges.

P2888

1471-2407-11-130

P304

130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-130

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Polina Weitzenfeld

P577

2011-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51045109

http://www.w3.org/2001/XMLSchema#string

P6179

1008800943

http://www.w3.org/2001/XMLSchema#string

P698

21486440

http://www.w3.org/2001/XMLSchema#string

P921

P932

3095565

http://www.w3.org/2001/XMLSchema#string